| UK-Odd Summary - French arrest "father" of 55 children in suspect benefits scam
|
| |
| “Asian Living Showcase 2010" to be kicking off now for the first time in Thailand” - Given with Thai economy’s potential growth, entrepreneurs from China led by Chinese state-owned exhibition agency will parade to participate the first-time showcase being held in Thailand – the "Asian
|
| |
| Ryan Leaf quietly returns home to build a life - Ryan Leaf is up early each day and often out the door before his parents get up. He wants to stay busy, see people if he can. It's a routine he needs.
|
| |
| Business & Finance - Living with growth - Lawrence Zammit The National Statistics Office issues last Tuesday the data for the second quarter of the domestic product. The top line data shows that in real...
|
| |
| Pension Consultant Conflicts of Interests (April 1, 2002 ) - Update Regarding Pension Consultant Conflicts of Interest Recent articles in the New York Times and
|
| |
| Greens carbon tax idea wins supporters - KEY supporters of the government's climate-change policies are backing an alternative proposal for a two-year carbon tax to break a deadlock on the emissions trading scheme.
|
| |
| Iran says it will release American hiker Sarah Shourd - In a gesture coinciding with the end of Islam's holiest month, a traditional time of clemency, Iran has announced it will release Sarah Shourd, one of three American hikers accused of illegally entering the country more than 13 months ago.
|
| |
| Dateline Shenzhen: Hu Wants My Wallet - China just celebrated a big event — the 30th anniversary of the launch of Shenzhen, the country's primary Special Economic Zone, located on the outskirts of Hong Kong. President Hu Jintao was there for the occasion — and so was The Globalist's editor-in-chief.
|
| |
| Notorious Rio Neighborhood on Media Roller Coaster - Our Brazil blogger reports on days of media access and insight, followed by a return to business as usual.
|
| |
| Genzyme Investors Push for Sanofi Bid of $75 a Share - Sanofi-Aventis SA may need to raise its bid for Genzyme Corp. to at least $75 a share, or about $19.1 billion, to gain support from board members at the U.S. biotechnology company, including those loyal to investor Carl C. Icahn, according to a person familiar with the process.
|
| |
|
|
| |
| | | | | | | | | |
